Derek B Oien - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Derek B Oien

Showing results (21-30 of 23) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 23 results.

Blood Advances|May 15, 2023

BET inhibition targets ABC-DLBCL constitutive B-cell receptor signaling through PAX5Derek B Oien, Samanta Sharma, Maureen M Hattersley, et al.

Cancers|September 28, 2021

Quinacrine Induces Nucleolar Stress in Treatment-Refractory Ovarian Cancer Cell LinesDerek B Oien, Upasana Ray, Christopher L Pathoulas, et al.

NPJ Precision Oncology|December 27, 2022

The landscape of therapeutic vulnerabilities in EGFR inhibitor osimertinib drug tolerant persister cellsSteven W Criscione, Matthew J Martin, Derek B Oien, et al.

Pageof 3

Search research articles

Showing results (21-30 of 23) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 23 results.

Blood Advances|May 15, 2023

BET inhibition targets ABC-DLBCL constitutive B-cell receptor signaling through PAX5Derek B Oien, Samanta Sharma, Maureen M Hattersley, et al.

Cancers|September 28, 2021

Quinacrine Induces Nucleolar Stress in Treatment-Refractory Ovarian Cancer Cell LinesDerek B Oien, Upasana Ray, Christopher L Pathoulas, et al.

NPJ Precision Oncology|December 27, 2022

The landscape of therapeutic vulnerabilities in EGFR inhibitor osimertinib drug tolerant persister cellsSteven W Criscione, Matthew J Martin, Derek B Oien, et al.

Pageof 3